ReviewNeuro-oncology2019

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.

Alireza Mansouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.